Therapeuticsmd (TXMD) Reports In-Line Q1 Loss of 6c/Share
Therapeuticsmd (NYSE: TXMD) reported Q1 EPS of ($0.06), in-line ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
